News Image

Alpha Tau Medical Announces Second Quarter 2024 Financial Results and Provides Corporate Update

Provided By GlobeNewswire

Last update: Aug 14, 2024

- First patient treated in May for liver metastases from colorectal cancer -

- Publication in June in Cancers journal of long-term safety and efficacy data in multiple hard-to-treat superficial cancers, with an overall response rate of almost 100% in treated lesions, no moderate or severe long-term toxicities noted, and a 2-year local recurrence-free survival was estimated at 77% -

Read more at globenewswire.com

ALPHA TAU MEDICAL LTD -27

NASDAQ:DRTSW (5/30/2025, 8:00:01 PM)

0.21

-0.04 (-16%)


ALPHA TAU MEDICAL LTD

NASDAQ:DRTS (5/30/2025, 8:00:01 PM)

2.985

-0.02 (-0.5%)



Find more stocks in the Stock Screener

Follow ChartMill for more